EFFECT OF ANESTHESİA TECHNIQUES ON POSTOPERATİVE COGNİTİVE DYSFUNCTION FOR MMSE AND NSE LEVEL

Sponsor
Erzincan University (Other)
Overall Status
Unknown status
CT.gov ID
NCT04279132
Collaborator
(none)
80
1
4
20

Study Details

Study Description

Brief Summary

The aim of this study is to compare the effects of total intravenous anesthesia and inhalation anesthesia methods on postoperative cognitive dysfunction according to Mini Mental State Examination scores and Neuron Specific Enolase levels in lumbar disc herniectomy operations.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: POSTOPERATIVE COGNITIVE DYSFUNCTION

Study Design

Study Type:
Observational [Patient Registry]
Anticipated Enrollment :
80 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
THE EFFECT OF TOTAL INTRAVENOUS ANESTHESIA AND INHALATION ANESTHESIA TECHNIQUES FOR MINI MENTAL STATE EXAMINATION TEST AND NEURON SPECIFIC ENOLASE LEVEL IN LUMBAR DISK HERNIECTOMY OPERATIONS
Anticipated Study Start Date :
Mar 21, 2020
Anticipated Primary Completion Date :
May 21, 2020
Anticipated Study Completion Date :
Jul 21, 2020

Arms and Interventions

Arm Intervention/Treatment
TOTAL INTRAVENOUS ANESTHESIA

Behavioral: POSTOPERATIVE COGNITIVE DYSFUNCTION
NEURON SPECIFIC ENOLASE LEVELS IN LUMBAR DISC HERNIECTOMY WITH GENERAL ANESTHESIA MODALITIES

INHALATION ANESTHESIA

Behavioral: POSTOPERATIVE COGNITIVE DYSFUNCTION
NEURON SPECIFIC ENOLASE LEVELS IN LUMBAR DISC HERNIECTOMY WITH GENERAL ANESTHESIA MODALITIES

Outcome Measures

Primary Outcome Measures

  1. MINI MENTAL STATE EXAMINATION TEST [1 MONTH]

    BELOW 27 SCORE IS ASSOSIATED WITH POSTOPERATIVE COGNITIVE DYSFUNCTION

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:

-Lumbal disc herniectomy operation 18-65 age

Exclusion Criteria:
  • Patients before and after the coronary artery bypass graft surgery

  • patients in the last trimester of pregnancy

  • patients with severe heart failure

  • liver failure

  • kidney failure

  • malignant hyperthermia

  • lactating patients

  • patients with vision or hearing problems

  • patients having difficulty in understanding and speaking Turkish

  • Parkinson's and Alzheimer's disease

  • alcohol and drug addicts

  • morbidly obese patients

  • intraoperative hypotension, hypertension and hypoxemia

Contacts and Locations

Locations

Site City State Country Postal Code
1 Erzincan Byu Erzincan Turkey

Sponsors and Collaborators

  • Erzincan University

Investigators

  • Principal Investigator: TÜLAY CEREN ÖLMEZTÜRK KARAKURT, ERZINCAN BYU

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
TULAY CEREN OLMEZTURK KARAKURT, MD, Erzincan University
ClinicalTrials.gov Identifier:
NCT04279132
Other Study ID Numbers:
  • 19/10
First Posted:
Feb 20, 2020
Last Update Posted:
Feb 20, 2020
Last Verified:
Feb 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 20, 2020